Nutritional status and vitamin D3 during antimicrobial treatment

The Lancet

Volumn 377, Issue 9775, 2011, Pages 1407-1408

  Warmelink, Ina ^a   Van Altena, Richard ^a   Ten Hacken, Nick ^a   Van Der Werf, Tjip ^a   Van Der Veer, Eveline ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; VITAMIN D RECEPTOR; TUBERCULOSTATIC AGENT; VITAMIN;

ANTIMICROBIAL THERAPY; BODY WEIGHT; GENOTYPE; HUMAN; HYPERCALCEMIA; INFLAMMATION; LETTER; LUNG TUBERCULOSIS; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK ASSESSMENT; SPUTUM CULTURE; TREATMENT FAILURE; WEIGHT GAIN; DIET SUPPLEMENTATION; MICROBIOLOGY; NOTE; SPUTUM; WEIGHT REDUCTION;

ANTITUBERCULAR AGENTS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; HUMANS; NUTRITIONAL STATUS; SPUTUM; TUBERCULOSIS, PULMONARY; VITAMINS; WEIGHT LOSS;

EID: 79955389344     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60576-X     Document Type: Letter

References (5)

1. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial Lancet 377 2011 242 250
2. I Warmelink, NH Ten Hacken, TS van der Werf, R van Altena Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity Br J Nutr 105 2011 400 408
3. F Krapp, JC Veliz, E Cornejo, E Gotuzzo, C Seas Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru Int J Tuberc Lung Dis 12 2008 1153 1159
4. H McIlleron, ML Watkins, PI Folb, SR Ress, RJ Wilkinson Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis Tuberculosis 87 2007 557 564 (Pubitemid 47595480)
5. PB Soeters, RF Grimble Dangers and benefits of the cytokine mediated response to injury and infection Clin Nutr 28 2009 583 596